154 related articles for article (PubMed ID: 29618931)
1. Upregulated
Wang X; Zhang J; Wang Y; Tu M; Wang Y; Shi G
Onco Targets Ther; 2018; 11():1697-1706. PubMed ID: 29618931
[TBL] [Abstract][Full Text] [Related]
2. Potential biomarkers and the molecular mechanism associated with DLL4 during renal cell carcinoma progression.
Wang X; Zhang J; Wang Y; Wang Y; Yu W; Shi G
Am J Med Sci; 2022 Aug; 364(2):220-228. PubMed ID: 35289275
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma.
Zhang H; Zou J; Yin Y; Zhang B; Hu Y; Wang J; Mu H
PeerJ; 2019; 7():e8096. PubMed ID: 31788359
[TBL] [Abstract][Full Text] [Related]
4. Biomarker Screening and Prognostic Significance Analysis for Renal Cell Carcinoma.
Meng X; Yuan H; Li W; Xiao W; Zhang X
Int J Gen Med; 2021; 14():5255-5267. PubMed ID: 34522125
[TBL] [Abstract][Full Text] [Related]
5. A 44-gene set constructed for predicting the prognosis of clear cell renal cell carcinoma.
Wang Y; Wang Y; Liu F
Int J Mol Med; 2018 Dec; 42(6):3105-3114. PubMed ID: 30272265
[TBL] [Abstract][Full Text] [Related]
6. Delta-like ligand 4: A predictor of poor prognosis in clear cell renal cell carcinoma.
Wang W; Yu Y; Wang Y; Li X; Bao J; Wu G; Chang H; Shi T; Yue Z
Oncol Lett; 2014 Dec; 8(6):2627-2633. PubMed ID: 25364440
[TBL] [Abstract][Full Text] [Related]
7. Identification of Hub Genes Associated With Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis.
Huang H; Zhu L; Huang C; Dong Y; Fan L; Tao L; Peng Z; Xiang R
Front Oncol; 2021; 11():726655. PubMed ID: 34660292
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis of C3 and CXCR4 demonstrates their potential as prognostic biomarkers in clear cell renal cell carcinoma (ccRCC).
Quan J; Bai Y; Yang Y; Han EL; Bai H; Zhang Q; Zhang D
BMC Cancer; 2021 Jul; 21(1):814. PubMed ID: 34266404
[TBL] [Abstract][Full Text] [Related]
9. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
11. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database.
Xiao GF; Yan X; Chen Z; Zhang RJ; Liu TZ; Hu WL
Front Genet; 2020; 11():810. PubMed ID: 33014010
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic mechanism of natural astaxanthin against renal clear cell carcinoma based on network pharmacology and bioinformatics].
Gao J; Yang D; Cao R; Pan X; Xia J
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Dec; 41(12):1763-1772. PubMed ID: 35012906
[TBL] [Abstract][Full Text] [Related]
14. Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell Carcinoma.
Wei Y; Chen X; Ren X; Wang B; Zhang Q; Bu H; Qian J; Shao P
Front Genet; 2021; 12():680369. PubMed ID: 34306023
[TBL] [Abstract][Full Text] [Related]
15. Integrated bioinformatics analysis for the identification of potential key genes affecting the pathogenesis of clear cell renal cell carcinoma.
Cui H; Xu L; Li Z; Hou KZ; Che XF; Liu BF; Liu YP; Qu XJ
Oncol Lett; 2020 Aug; 20(2):1573-1584. PubMed ID: 32724399
[TBL] [Abstract][Full Text] [Related]
16. The expression and prognostic value of RNA binding proteins in clear cell renal cell carcinoma.
Li CX; Chen J; Xu ZG; Yiu WK; Lin YT
Transl Cancer Res; 2020 Dec; 9(12):7415-7431. PubMed ID: 35117342
[TBL] [Abstract][Full Text] [Related]
17. The discovery of promising candidate biomarkers in kidney renal clear cell carcinoma: evidence from the in-depth analysis of high-throughput data.
Li X; Li M; Zhao T; Zhang J
Am J Cancer Res; 2023; 13(9):4288-4304. PubMed ID: 37818073
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatic identification of key genes and analysis of prognostic values in clear cell renal cell carcinoma.
Luo T; Chen X; Zeng S; Guan B; Hu B; Meng Y; Liu F; Wong T; Lu Y; Yun C; Hocher B; Yin L
Oncol Lett; 2018 Aug; 16(2):1747-1757. PubMed ID: 30008862
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma.
Zhang X; Wang Z; Zeng Z; Shen N; Wang B; Zhang Y; Shen H; Lu W; Wei R; Ma W; Wang C
Cancer Cell Int; 2021 Apr; 21(1):222. PubMed ID: 33865387
[TBL] [Abstract][Full Text] [Related]
20. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X
BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
